Dr. Fumihiko Takeshita, M.D., Ph.D.
Senior Director Vaccine Business Strategy Department, Vaccine Business Intelligence Division, DAIICHI SANKYO CO. Ltd.
DATE of BIRTH: March 23th, 1970
DAIICHI SANKYO CO. LTD.Vaccine Business Intelligence Department Vaccine Business Strategy Division
1994 Graduated from Yokohama City University School of Medicine, Yokohama, Japan (Licensure to practice medicine, Ministry of Health and Welfare, Japan)
1998 Graduate Student/Junior and Senior Resident Physician, Department of Internal Medicine (Rheumatology, Hematology, Respiratory Medicine, Gastroenterology, and Infectious Diseases, Yokohama City University Hospital, Yokohama, Japan
1998-2001 Postdoctoral Research Fellow, Section of Retroviral Immunology, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Maryland, USA
2001-2004 Research Fellow, Department of Microbiology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
2004-2006 Assistant Professor of Medical Sciences (Microbiology and Molecular Biodefense Research), Yokohama City University, Yokohama, Japan
2006-2010 Associate Professor of Medical Sciences (Microbiology and Molecular Biodefense Research), Yokohama City University, Yokohama, Japan
2010-2012 Unit Leader & Manager, Vaccine Research Unit (Kasai) & Adjuvant Research Unit (Osaka), Vaccine Business Planning Department, Daiichi Sannkyo, Co., Ltd.
2012-2013 Group Manager, Project Management, Clinical Development & Medical Affairs, Japan Vaccine Co., Ltd
2013-present Senior Director, Vaccine Business Strategy Department, Vaccine Business Intelligence Division, Daiichi Sankyo Co., Ltd.
・Licensure to practice medicine, Ministry of Health and Welfare, Japan, May 1994
・Licensure to management of radioactive products, Ministry of Education, Culture, Sports, Science and Technology, December 2002
・Keystone Symposia, NIAID Award: Kobiyama K, Jounai N, and Takeshita F. Autophagy-related Atg family members associate with the dsRNA-mediated innate anti-virus immune pathway. Keystone Symposia on Molecular and Cellular Biology. February 25-March 1. 2007. Keystone, Colorado, USA
・Yokohama Medical Award: Takeshita F. Enhancement of DNA vaccine immunogenicity by using endogenous innate immune activating molecules. July 2004. Yokohama, Japan